tldrdailynews.com logo

Tonix's New Fibromyalgia Drug Gains FDA Approval Amid Strong Trials

1 min read
Source: Stock Titan
Tonix's New Fibromyalgia Drug Gains FDA Approval Amid Strong Trials
Photo: Stock Titan
TL;DR

Tonix Pharmaceuticals received FDA approval for Tonmya™, a non-opioid, sublingual tablet for fibromyalgia in adults, marking the first new treatment in over 15 years. The drug demonstrated significant pain reduction in Phase 3 trials and is expected to launch in Q4 2025, targeting over 10 million affected U.S. adults.

Topics:businesshealth#clinical-trials#fda-approval#fibromyalgia#health#non-opioid#tonmya
Share this article
  1. First New Fibromyalgia Drug in 15 Years: Tonix's Tonmya Approved for 10M+ US Patients After Strong Trial Results  Stock Titan
  2. Anticipating TNX-102 SL's Addition to the Fibromyalgia Toolkit, with Andrew Sharobeem, DO  HCPLive
  3. US FDA approves Tonix Pharma's drug to manage pain related to chronic condition  Reuters
  4. Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights  GlobeNewswire
  5. Tonix Pharmaceuticals stock halted ahead of FDA approval news  Investing.com

Want the full story? Read the original reporting

Read on Stock Titan